Literature DB >> 15732884

Caffeine and psychiatric symptoms: a review.

Pamela Broderick1, Ashley B Benjamin.   

Abstract

Caffeine is a widely used psychoactive substance that has the potential to contribute to many psychiatric symptoms. This review article aims to address the specific research studies and case reports that relate caffeine to psychiatric symptoms. Caffeine can cause anxiety symptoms in normal individuals, especially in vulnerable patients, like those with pre-existing anxiety disorders. Caffeine use is also associated with symptoms of depression due to either a self-medication theory, or a theory that caffeine itself causes changes in mood. Psychosis can be induced in normal individuals ingesting caffeine at toxic doses, and psychotic symptoms can also be worsened in schizophrenic patients using caffeine. Sleep and symptoms of ADHD may be altered by caffeine as well. Prevention of caffeine-induced psychiatric symptoms is possible by recognizing, educating, and treating patients using a tapering approach.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15732884

Source DB:  PubMed          Journal:  J Okla State Med Assoc        ISSN: 0030-1876


  20 in total

Review 1.  Caffeine use in children: what we know, what we have left to learn, and why we should worry.

Authors:  Jennifer L Temple
Journal:  Neurosci Biobehav Rev       Date:  2009-01-20       Impact factor: 8.989

2.  A comparison of the associations of caffeine and cigarette use with depressive and ADHD symptoms in a sample of young adult smokers.

Authors:  Tyanne Dosh; Tysa Helmbrecht; Joye Anestis; Greg Guenthner; Thomas H Kelly; Catherine A Martin
Journal:  J Addict Med       Date:  2010-03       Impact factor: 3.702

3.  A1 adenosine receptor-mediated GIRK channels contribute to the resting conductance of CA1 neurons in the dorsal hippocampus.

Authors:  Chung Sub Kim; Daniel Johnston
Journal:  J Neurophysiol       Date:  2015-02-04       Impact factor: 2.714

Review 4.  Health effects of energy drinks on children, adolescents, and young adults.

Authors:  Sara M Seifert; Judith L Schaechter; Eugene R Hershorin; Steven E Lipshultz
Journal:  Pediatrics       Date:  2011-02-14       Impact factor: 7.124

Review 5.  Pharmacological challenge studies with acute psychosocial stress.

Authors:  Kathryne Van Hedger; Anya K Bershad; Harriet de Wit
Journal:  Psychoneuroendocrinology       Date:  2017-08-22       Impact factor: 4.905

6.  Sensorimotor gating is disrupted by acute but not chronic systemic exposure to caffeine in mice.

Authors:  Sylvain Dubroqua; Benjamin K Yee; Philipp Singer
Journal:  Psychopharmacology (Berl)       Date:  2014-04-12       Impact factor: 4.530

7.  Effects of blue light and caffeine on mood.

Authors:  Johan G Ekström; C Martyn Beaven
Journal:  Psychopharmacology (Berl)       Date:  2014-03-04       Impact factor: 4.530

8.  Depression, anxiety, and history of substance abuse among Norwegian inmates in preventive detention: reasons to worry?

Authors:  Henning Værøy
Journal:  BMC Psychiatry       Date:  2011-03-10       Impact factor: 3.630

9.  Effect of lisdexamfetamine dimesylate on sleep in adults with attention-deficit/hyperactivity disorder.

Authors:  Lenard A Adler; David Goodman; Richard Weisler; Mohamed Hamdani; Thomas Roth
Journal:  Behav Brain Funct       Date:  2009-08-03       Impact factor: 3.759

10.  Complementary medicine, exercise, meditation, diet, and lifestyle modification for anxiety disorders: a review of current evidence.

Authors:  J Sarris; S Moylan; D A Camfield; M P Pase; D Mischoulon; M Berk; F N Jacka; I Schweitzer
Journal:  Evid Based Complement Alternat Med       Date:  2012-08-27       Impact factor: 2.629

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.